A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI.
<h4>Context</h4>There is no rapid and cost effective tool that can be implemented as a front-line screening tool for Alzheimer's disease (AD) at the population level.<h4>Objective</h4>To generate and cross-validate a blood-based screener for AD that yields acceptable acc...
Guardado en:
Autores principales: | Sid E O'Bryant, Guanghua Xiao, Robert Barber, Ryan Huebinger, Kirk Wilhelmsen, Melissa Edwards, Neill Graff-Radford, Rachelle Doody, Ramon Diaz-Arrastia, Texas Alzheimer's Research & Care Consortium, Alzheimer's Disease Neuroimaging Initiative |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/78929cbbf9f34eabb44c5fc8dbcf2cd4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pairwise Correlation Analysis of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Dataset Reveals Significant Feature Correlation
por: Erik D. Huckvale, et al.
Publicado: (2021) -
Relationship between plasma analytes and SPARE-AD defined brain atrophy patterns in ADNI.
por: Jon B Toledo, et al.
Publicado: (2013) -
Identification of Disease-Related Genes That Are Common between Alzheimer’s and Cardiovascular Disease Using Blood Genome-Wide Transcriptome Analysis
por: Taesic Lee, et al.
Publicado: (2021) -
Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers.
por: Daoqiang Zhang, et al.
Publicado: (2012) -
Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization
por: Yeonwoo Chung, et al.
Publicado: (2021)